ARS Pharmaceuticals, Inc. (SPRY) Insider Ownership

Historic Insider Ownership Trends

As of May 30, 2026, the three largest insider holders of SPRY are Capital Management, L.P. Ra (Director, 9.96Mn shares), James E Flynn (TenPercentOwner, 9.77Mn shares), Capital Management, L.P. Ra (Director, 8.56Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Capital Management, L.P. Ra - 0 9,958,073 27 Mar, 2024
James E Flynn - 0 9,774,508 01 Jul, 2025
Richard E Lowenthal President And Ceo 0 7,175,952 19 Dec, 2024
Brian Dorsey Chief Operating Officer 10,789 0 14 Nov, 2025
Alexander A Fitzpatrick Chief Legal Officer 89,613 0 22 May, 2025
Laura Shawver Chief Executive Officer 254,242 0 09 Aug, 2022
Pratik Shah - 0 4,474,554 14 Nov, 2025
Kathleen D. Scott Chief Financial Officer 10,042 0 22 Aug, 2025
Russ Hawkinson Sr. Vice President Of Finance 37,251 0 04 May, 2022
Jonathan Piazza Chief Financial Officer 69,225 0 04 May, 2022
Naomi Hunder Chief Medical Officer 54,427 0 04 May, 2022
Valerie Odegard President And Cso 61,639 0 04 May, 2022
Eric Karas Chief Commercial Officer 10,315 0 03 Jul, 2025
Sarina Tanimoto Chief Medical Officer 0 7,968,676 19 Dec, 2024
Rajeev Dadoo - 0 3,009,677 10 Nov, 2022
Michael Kelly - 0 83,225 10 Nov, 2022

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
02 Jan, 2026 Richard E Lowenthal Stock option (right to buy) A 875,000 $0.00 875,000 D A
02 Jan, 2026 Kathleen D. Scott Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Kathleen D. Scott Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Sarina Tanimoto Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Eric Karas Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Alexander A Fitzpatrick Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Justin Chakma Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Sarina Tanimoto Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Brian Dorsey Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Eric Karas Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Justin Chakma Stock option (right to buy) A 240,000 $0.00 240,000 D A
02 Jan, 2026 Richard E Lowenthal Stock option (right to buy) A 875,000 $0.00 875,000 D A
02 Jan, 2026 Richard E Lowenthal Stock Option (right to buy) A 240,000 $0.00 240,000 I A
02 Jan, 2026 Richard E Lowenthal Stock Option (right to buy) A 240,000 $0.00 240,000 I A
02 Jan, 2026 Sarina Tanimoto Stock Option (right to buy) A 875,000 $0.00 875,000 I A
02 Jan, 2026 Sarina Tanimoto Stock Option (right to buy) A 875,000 $0.00 875,000 I A
12 Nov, 2025 Justin Chakma Common Stock A 30,000 $0.84 166,380 D M
12 Nov, 2025 Pratik Shah Common Stock D 250,000 $0.00 4,574,554 I G
12 Nov, 2025 Justin Chakma Common Stock A 30,000 $0.84 166,380 D M
13 Nov, 2025 Brian Dorsey Common Stock A 21,828 $0.64 32,617 D M